| 发明名称 |
Compositions and methods for treatment of hematological malignancies |
| 摘要 |
Use of a chimeric protein selected from the group consisting of CTLA4- FasL and CD40-FasL proteins for treatment of lymphoma and/or a multiple myeloma and/or a leukemia as described herein, and pharmaceutical compositions and methods of treatment thereof. |
| 申请公布号 |
AU2011309689(B2) |
申请公布日期 |
2015.01.15 |
| 申请号 |
AU20110309689 |
申请日期 |
2011.09.28 |
| 申请人 |
KAHR MEDICAL LTD.;HADASIT MEDICAL RESEARCH SERVICES & DEVELOPMENT LTD. |
发明人 |
DRANITZKI ELHALEL, MICHAL |
| 分类号 |
C07K14/705;A61K38/17;A61P35/00;A61P35/02 |
主分类号 |
C07K14/705 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
